Clinical Sandoz biosimilar trial hailed as 'landmark' Patients switched between the originator and the near-copy.
News Science minister Johnson concerned over EU science cash EU science funding would remain, at least for the time being.
News UK science funding uncertain after Brexit vote UK government says funding will continue until Brexit is resolved.
US FDA fast-tracks review of Roche's potential MS blockbuster Regulator to make decision by year end.
Sales & Marketing Biotech is back, with Craig Ackerman In Philadelphia this month, pharmaphorum spoke with Craig Ackerman, a partner at the Alexander Group, about launches, AI best practices, and more.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
